These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 447838

  • 21. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS, Bastl C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P.
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [Abstract] [Full Text] [Related]

  • 22. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA.
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [Abstract] [Full Text] [Related]

  • 23. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R, Deibert D, Hendler R, Felig P, Soman V.
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [Abstract] [Full Text] [Related]

  • 24. Somatostatin infusion inhibits glucose production in burn patients.
    Wolfe RR, Burke JF.
    Circ Shock; 1982 May; 9(5):521-7. PubMed ID: 6129073
    [Abstract] [Full Text] [Related]

  • 25. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI, Liljenquist JE, Williams PE, Lacy WW, Cherrington AD.
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [Abstract] [Full Text] [Related]

  • 29. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
    Nair KS.
    J Clin Endocrinol Metab; 1987 May; 64(5):896-901. PubMed ID: 2881943
    [Abstract] [Full Text] [Related]

  • 30. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E, Sarantakis D.
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [Abstract] [Full Text] [Related]

  • 31. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
    Paolisso G, Scheen AJ, Verdin EM, Luyckx AS, Lefebvre PJ.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
    [Abstract] [Full Text] [Related]

  • 32. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.
    Bomboy JD, Lewis SB, Lacy WW, Sinclair-Smith BC, Liljenquist JE.
    Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074
    [Abstract] [Full Text] [Related]

  • 33. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R, Wahren J, Felig P.
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [Abstract] [Full Text] [Related]

  • 34. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
    Ward WK, Best JD, Halter JB, Porte D.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
    [Abstract] [Full Text] [Related]

  • 35. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS, Hendler R, DeFronzo R, Wahren J, Felic P.
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [Abstract] [Full Text] [Related]

  • 36. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD, Schaeffer L, Shragg P, Kolterman OG.
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [Abstract] [Full Text] [Related]

  • 37. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G, Scheen AJ, Luyckx AS, Lefebvre PJ.
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [Abstract] [Full Text] [Related]

  • 38. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia.
    Ferrannini E, DeFronzo RA, Sherwin RS.
    Am J Physiol; 1982 Feb; 242(2):E73-81. PubMed ID: 7039338
    [Abstract] [Full Text] [Related]

  • 39. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
    Luyckx AS, Mendoza E, Lefebvre PJ.
    Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333
    [Abstract] [Full Text] [Related]

  • 40. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP, Benson JW, Walter RM, Ensinck JW.
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.